HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroyasu Uzui Selected Research

Infarction (Infarctions)

10/2018Cardiovascular Outcomes in Patients With Previous Myocardial Infarction and Mild Diabetes Mellitus Following Treatment With Pioglitazone: Reports of a Randomised Trial From The Japan Working Group for the Assessment Whether Pioglitazone Protects DM Patients Against Re-Infarction (PPAR Study).
6/2012Acute hyperglycemia causes microvascular damage, leading to poor functional recovery and remodeling in patients with reperfused ST-segment elevation myocardial infarction.
3/2012Beneficial effects of statin treatment on coronary microvascular dysfunction and left ventricular remodeling in patients with acute myocardial infarction.
8/2006Comparative assessment of 18F-fluorodeoxyglucose PET and 99mTc-tetrofosmin SPECT for the prediction of functional recovery in patients with reperfused acute myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroyasu Uzui Research Topics

Disease

13Heart Failure
12/2022 - 06/2003
10Myocardial Infarction
11/2021 - 10/2005
8Coronary Artery Disease (Coronary Atherosclerosis)
08/2022 - 06/2005
7Atrial Fibrillation
12/2022 - 12/2018
5Atherosclerosis
11/2018 - 12/2002
4Hyperglycemia
07/2022 - 04/2011
4Ventricular Fibrillation
01/2022 - 01/2019
4Cardiovascular Diseases (Cardiovascular Disease)
11/2021 - 02/2003
4Infarction (Infarctions)
10/2018 - 08/2006
3Inflammation (Inflammations)
12/2022 - 10/2006
3Heart Diseases (Heart Disease)
11/2021 - 07/2004
3Unstable Angina
11/2021 - 08/2017
3Left Ventricular Dysfunction
10/2021 - 01/2020
3Cardiomyopathies (Cardiomyopathy)
04/2021 - 06/2003
3Stroke (Strokes)
11/2019 - 08/2017
3Hypertension (High Blood Pressure)
05/2014 - 11/2005
3Atherosclerotic Plaque (Atheroma)
10/2011 - 04/2002
2Acute Coronary Syndrome
07/2022 - 10/2021
2Fibrosis (Cirrhosis)
01/2021 - 01/2018
2Torsades de Pointes (Torsade de Pointes)
01/2021 - 01/2019
2Prostatic Neoplasms (Prostate Cancer)
01/2021 - 01/2019
2Atrial Flutter (Flutter, Atrial)
01/2020 - 01/2020
2Type 2 Diabetes Mellitus (MODY)
10/2019 - 04/2011
2Ventricular Remodeling
08/2017 - 03/2012
1Hyperuricemia
12/2022
1Overweight
08/2022
1Cardiac Arrhythmias (Arrythmia)
08/2022
1Long QT Syndrome
01/2022
1Polymorphic catecholergic ventricular tachycardia
01/2022
1Amyloidosis
01/2022
1Ventricular Premature Complexes (Premature Ventricular Contraction)
09/2021
1Chronic Limb-Threatening Ischemia
07/2021
1Wounds and Injuries (Trauma)
07/2021
1Cachexia
04/2021
1Cardiomegaly (Heart Hypertrophy)
01/2021
1Hypernatremia
01/2020
1Body Weight (Weight, Body)
01/2020
1Ventricular Tachycardia
01/2020
1Cardiac Tamponade
11/2019
1Heart Arrest (Cardiac Arrest)
01/2019
1Coma (Comas)
01/2019
1Neoplasm Metastasis (Metastasis)
01/2019
1Non-ST Elevated Myocardial Infarction
01/2019
1Vascular Ring
11/2018
1Stable Angina
11/2018

Drug/Important Bio-Agent (IBA)

12Matrix Metalloproteinases (MMPs)IBA
06/2022 - 12/2002
6Glucose (Dextrose)FDA LinkGeneric
12/2022 - 08/2006
5Metalloproteases (Metalloproteinases)IBA
06/2022 - 12/2002
4MagnesiumIBA
01/2006 - 02/2003
3erucylphosphocholineIBA
10/2019 - 01/2012
3LipidsIBA
11/2018 - 10/2005
3Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2015 - 01/2004
21,5-anhydroglucitolIBA
07/2022 - 10/2016
2Tissue Inhibitor of Metalloproteinase-1IBA
06/2022 - 01/2014
2SodiumIBA
06/2022 - 01/2020
2C-Reactive ProteinIBA
04/2021 - 11/2020
2Biomarkers (Surrogate Marker)IBA
10/2019 - 10/2016
2oxidized low density lipoproteinIBA
11/2018 - 12/2002
2Glycoside Hydrolase InhibitorsIBA
08/2017 - 04/2011
2Acetylcysteine (Siran)FDA LinkGeneric
03/2015 - 07/2009
2Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2015 - 03/2012
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2012 - 10/2005
2CytokinesIBA
10/2006 - 12/2002
1Uric Acid (Urate)IBA
12/2022
1omega-Chloroacetophenone (Mace)IBA
08/2022
1Interleukin-6 (Interleukin 6)IBA
06/2022
1Amyloid (Amyloid Fibrils)IBA
01/2022
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
01/2022
1Adrenergic Agents (Adrenergic Drugs)IBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1evolocumabIBA
07/2021
1Dichlorodiphenyldichloroethane (DDD)IBA
04/2021
1p38 Mitogen-Activated Protein KinasesIBA
01/2021
1Androgen Antagonists (Antiandrogens)IBA
01/2021
1CollagenIBA
01/2021
1GonadotropinsIBA
01/2021
1Hormones (Hormone)IBA
01/2021
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2021
1Glycoproteins (Glycoprotein)IBA
11/2020
1TenascinIBA
11/2020
1TolvaptanFDA Link
01/2020
1CreatinineIBA
01/2020
1Troponin T (Troponin T1)IBA
01/2020
1DabigatranFDA Link
11/2019
1AntidotesIBA
11/2019
1AnticoagulantsIBA
11/2019
1Chemokine CXCL12IBA
10/2019
1TroponinIBA
01/2019
1IceIBA
12/2018
1PTX3 proteinIBA
11/2018

Therapy/Procedure

8Therapeutics
01/2021 - 11/2005
7Catheter Ablation
12/2022 - 11/2019
4Percutaneous Coronary Intervention
08/2022 - 08/2017
2Catheters
09/2021 - 12/2018
2Castration
01/2021 - 01/2019
1Cardiac Rehabilitation
10/2021
1Electrodes (Electrode)
09/2021
1Limb Salvage
07/2021
1Surgical Amputation (Amputations)
07/2021
1Induced Hypothermia
01/2019